Journal article
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
Abstract
BACKGROUND: Subclinical atrial fibrillation is short-lasting and asymptomatic and can usually be detected only by long-term continuous monitoring with pacemakers or defibrillators. Subclinical atrial fibrillation is associated with an increased risk of stroke by a factor of 2.5; however, treatment with oral anticoagulation is of uncertain benefit.
METHODS: We conducted a trial involving patients with subclinical atrial fibrillation lasting 6 …
Authors
Healey JS; Lopes RD; Granger CB; Alings M; Rivard L; McIntyre WF; Atar D; Birnie DH; Boriani G; Camm AJ
Journal
The New England Journal of Medicine, Vol. 390, No. 2, pp. 107–117
Publisher
Massachusetts Medical Society
Publication Date
January 11, 2024
DOI
10.1056/nejmoa2310234
ISSN
0028-4793